Osthole relieves diabetics cardiac autonomic neuropathy associated with P2X3 receptor in ratstellate ganglia.
Animals
Blood Pressure
/ drug effects
Coumarins
/ pharmacology
Diabetes Mellitus, Experimental
/ drug therapy
Diabetes Mellitus, Type 2
/ drug therapy
Diabetic Neuropathies
/ drug therapy
Ganglia
/ drug effects
Male
Molecular Docking Simulation
Rats, Sprague-Dawley
Receptors, Purinergic P2X3
/ drug effects
Streptozocin
/ pharmacology
Diabetic cardiac autonomic neuropathy
Osthole
P2X3 receptor
Stellate ganglia
Journal
Brain research bulletin
ISSN: 1873-2747
Titre abrégé: Brain Res Bull
Pays: United States
ID NLM: 7605818
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
05
06
2019
revised:
20
01
2020
accepted:
24
01
2020
pubmed:
6
2
2020
medline:
18
8
2021
entrez:
5
2
2020
Statut:
ppublish
Résumé
Diabetic cardiac autonomic neuropathy (DCAN) is a serious complication of diabetes mellitus, which often leads to cardiac dysfunction and even threatens patients' life. Osthole, a natural coumarin derivative, has anti-inflammatory, anti-oxidant and antihypertensive effects. The P2X3 receptor is related to DCAN. The objective of this study will investigate whether osthole relieves DCAN associated with the P2X3 receptor in the stellate ganglia of diabetic rats. A type 2 diabetes mellitus rat model was induced by a combination of diet and streptozotocin. Our results showed that osthole improved the abnormal changes of blood pressure, heart rate, and heart rate variability in diabetic rats and significantly reduced the up-regulated expression levels of the P2X3 receptor, tumor necrosis factor-α and interleukin-1β in stellate ganglia of diabetic rats. Meanwhile, osthole significantly decreased the elevated serum adrenaline concentration and phosphorylation level of extracellular regulated protein kinase 1/2. In addition, the molecular docking result indicated that osthole was a perfect fit for interacting with the P2X3 receptor. Overall, osthole alleviates the sympathetic relative excitation via inhibiting the expression of P2X3 receptors in the stellate ganglia, to achieve a balance between sympathetic and parasympathetic nerves, relieves the DCAN.
Identifiants
pubmed: 32017970
pii: S0361-9230(19)30446-0
doi: 10.1016/j.brainresbull.2020.01.017
pii:
doi:
Substances chimiques
Coumarins
0
Receptors, Purinergic P2X3
0
Streptozocin
5W494URQ81
osthol
XH1TI1759C
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
90-99Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no competing interests.